Senegalese Company Produces First Africa-Made Treatment for Sickle Cell Disease

A Senegalese pharmaceutical company has produced the first Africa-made treatment for sickle cell disease, a breakthrough that offers hope to millions of sufferers across the continent who have long relied on expensive imported medication. Teranga Pharma, based in Senegal, has developed Drepaf, a generic version of hydroxyurea, which the World Health Organization recommends as the […] The post…